Alkem Laboratories announced that a Wholly Owned Subsidiary (�WOS�) of the Company in the name of `Alixer Nexgen Therapeutics` has been incorporated on 12 July 2024 in India.Powered by Capital Market - Live News

Alkem Laboratories announced that the US FDA has issued an Establishment Inspection Report (EIR) for the manufacturing facility of the Company located at Baddi, India. The Inspection has been classified as Voluntary Action Indicated (VAI) and has been closed accordingly. Powered by Capital Market - Live News

Alkem Laboratories has agreed to invest Rs 30 crore in the (Pre-Series A) Compulsorily Convertible Preference Shares of M/s HaystackAnalytics. The proposed investment is a strategic investment by the company. It will help the company to participate in growing diagnostic space and leveraging Haystack`s expertise in advanced genomic data analysis to drive its business based on the detailed analytics from the generated reports. Powered by Capital Market - Live News

Alkem Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2024, inter alia, have recommended the final dividend of Rs 5 per equity Share (i.e. 250%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Alkem Laboratories rose 313.58% to Rs 293.56 crore in the quarter ended March 2024 as against Rs 70.98 crore during the previous quarter ended March 2023. Sales rose 1.14% to Rs 2935.82 crore in the quarter ended March 2024 as against Rs 2902.60 crore during the previous quarter ended March 2023.For the full year,net profit rose 82.47% to Rs 1795.77 crore in the year ended March 2024 as against Rs 984.17 crore during the previous year ended March 2023. Sales rose 9.21% to Rs 12667.58 crore in the year ended March 2024 as against Rs 11599.26 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales2935.822902.60 1 12667.5811599.26 9 OPM %13.6912.17 -17.7313.88 - PBDT463.29392.96 18 2443.921718.17 42 PBT379.86314.64 21 2144.621407.75 52 NP293.5670.98 314 1795.77984.17 82 Powered by Capital Market - Live News